Company: PCRX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001396814-25-000041
Chunk: 59

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 59
---
 10-K  |  Page F-31

Table of ContentsPACIRA BIOSCIENCES, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

accounts receivable and its write-off history. As of December 31, 2024, there were $0.4 million of allowances for credit losses on its accounts receivable. As of December 31, 2023, the Company did not deem any allowances for credit losses on its accounts receivable necessary.

NOTE 12—STOCKHOLDERS’ EQUITY

Common StockThe Company is authorized to issue up to 250,000,000 shares of common stock, of which 47,077,844 shares were issued and 46,240,604 shares were outstanding at December 31, 2024 and 46,481,174 shares were issued and outstanding at December 31, 2023.Preferred StockThe Company is authorized to issue up to 5,000,000 shares of preferred stock. No preferred stock was issued or outstanding at either December 31, 2024 or 2023.Accumulated Other Comprehensive Income (Loss)The following table illustrates the changes in the balances of the Company’s accumulated other comprehensive income (loss) for the periods presented (in thousands):Net Unrealized Gains(Losses) From Available-For-Sale InvestmentsUnrealized Foreign Currency TranslationAccumulated Other Comprehensive Income (Loss)Balance at December 31, 2021$139 $28 $167 Net unrealized loss on investments, net of tax (1)(662)— (662)Foreign currency translation adjustments— 115 115 Balance at December 31, 2022(523)143 (380)Net unrealized gain on investments, net of tax (1)647 — 647 Foreign currency translation adjustments— (20)(20)Balance at December 31, 2023124 123 247 Net unrealized gain on investments, net of tax (1)66 — 66 Foreign currency translation adjustments— 30 30 Balance at December 31, 2024$190 $153 $343 (1) Net of a nominal tax expense for the year ended December 31, 2024, and a $(0.2) million and $0.2 million tax (expense) benefit for the years ended December 31, 2023 and 2022,